期刊
UROLITHIASIS
卷 44, 期 1, 页码 45-50出版社
SPRINGER
DOI: 10.1007/s00240-015-0845-6
关键词
Hyperoxaluria calcium oxalate (CaOx); Microbiome; Enzymatic dissolution; Oxalate-degrading enzymes; Oxalate oxidase; Oxalate decarboxylase; Oxalyl-CoA decarboxlase
Renal urolithiasis is a pathological condition common to a multitude of genetic, physiological and nutritional disorders, ranging from general hyperoxaluria to obesity. The concept of quickly dissolving renal uroliths via chemolysis, especially calcium-oxalate kidney stones, has long been a clinical goal, but yet to be achieved. Over the past 25 years, there has been a serious effort to examine the prospects of using plant and microbial oxalate-degrading enzymes known to catabolize oxalic acid and oxalate salts. While evidence is emerging that bacterial probiotics can reduce recurrent calcium-oxalate kidney stone disease by lowering systemic hyperoxaluria, the possible use of free oxalate-degrading enzyme therapy remains a challenge with several hurdles to overcome before reaching clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据